Yeah, for sure. There are certainly other pots to draw from post approval but pre NICE reimbursement approval. Hopefully, Flaskworks is close. Everything I've seen lately from the experts at the FDA and the experts in the UK, manufacturing scale/automation to keep price reasonable is absolutely huge. The President of the BNOS even talked specifically about global manufacturing.
Market Data 
Markets 
AI
